CN1269506C - Prepared Chinese traditional medicine for alopecia - Google Patents
Prepared Chinese traditional medicine for alopecia Download PDFInfo
- Publication number
- CN1269506C CN1269506C CN 02139561 CN02139561A CN1269506C CN 1269506 C CN1269506 C CN 1269506C CN 02139561 CN02139561 CN 02139561 CN 02139561 A CN02139561 A CN 02139561A CN 1269506 C CN1269506 C CN 1269506C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- alopecia
- pericarpium citri
- citri reticulatae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Abstract
The present invention relates to a Chinese patent medicine preparation for preventing alopecia and restoring hair. The preparation is prepared from the following components, in the weight percentages, 1 to 20% of atractylodes rhizome, 1 to 12% of fried white atractylodes rhizome, 3 to 30% of pilose asiabell root, 2 to 27% of Chinese angelica, 1 to 18% of chuanxiong rhizome and 3 to 25% of bupleurum root. The present invention solves the technical problem that medicines with special therapeutic effect on alopecia seborrheica, praecox alopecia, alopecia areata and other hair diseases still do not exist at present. The preparation has stabile and reliable therapeutic effect on various hair diseases. The preparation can also be made into various dosage forms, comprising traditional Chinese medicine powder, pills, capsules, etc.
Description
Technical field
The present invention relates to a kind of medicinal preparation, especially a kind ofly be used for anti-loss and promote the Chinese patent medicine preparation of hair growth promoting.
Background technology
Alopecia has caused serious thought pressure to the patient, thereby normal work, study, life and doings are affected.Yet, still do not have hair diseases such as special effect medicine therapeutic seborrheic alopecia, sending alopecia early, alopecia areata, alopecia totalis, alopecia universalis, puerperal alopecia at present.
Summary of the invention
The invention solves the technical problem of hair illness such as no special effect medicine therapeutic seborrheic alopecia, sending alopecia early, alopecia areata, alopecia totalis, alopecia universalis, puerperal alopecia in the background technology.
Technical scheme of the present invention is: a kind of Chinese patent medicine preparation for the treatment of alopecia, and its special character is: it is Rhizoma Atractylodis 1%-20% that the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia is formed; Rhizoma Atractylodis Macrocephalae (parched) 1%-12%; Radix Codonopsis 3%-30%; Radix Angelicae Sinensis 2%-27%; Rhizoma Chuanxiong 1%-18%; Radix Bupleuri 3%-25%; Radix Astragali 1%-20%; Radix Polygoni Multiflori Preparata 0.5%-10%; Clear Rhizoma Pinelliae Preparata 0.5%-2%; Polyporus 1%-10%; Poria 0.5%-10%; Semen Plantaginis 0.5%-10%; Rhizoma Alismatis 0.5%-10%; Semen Coicis 3%-30%; Flos Carthami 3%-30%; Radix Saposhnikoviae 0.1%-10%; Radix Paeoniae Rubra 3%-30%; Radix Salviae Miltiorrhizae 3%-30%; Semen Persicae 3%-30%; Pericarpium Citri Reticulatae 5%-30%; Fructus Aurantii 1%-10%; Herba Pogostemonis 3%-30%; Herba Eupatorii 3%-30%; Herba Lycopi 3%-30%; Rhizoma Corydalis 3%-30%; Pericarpium Citri Reticulatae Viride 1%-30%; Cortex Magnoliae Officinalis 0.5%-20%; Radix Angelicae Dahuricae 1%-10%; Radix Platycodonis 3%-30%.
The percentage by weight of the Chinese patent medicine preparation of above-mentioned treatment alopecia consists of Rhizoma Atractylodis 8.6%; Rhizoma Atractylodis Macrocephalae (parched) 7%; Radix Codonopsis 4.1%; Radix Angelicae Sinensis 15%; Rhizoma Chuanxiong 4%; Radix Bupleuri 11%; The Radix Astragali 3.3%; Radix Polygoni Multiflori Preparata 3%; Clear Rhizoma Pinelliae Preparata 1.5%; Polyporus 1%; Poria 1.3%; Semen Plantaginis 0.7%; Rhizoma Alismatis 0.9%; Semen Coicis 3%; Flos Carthami 3%; Radix Saposhnikoviae 0.1%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 3%; Semen Persicae 3%; Pericarpium Citri Reticulatae 5%; Fructus Aurantii 1%; Herba Pogostemonis 3%; Herba Eupatorii 3%; The Herba Lycopi 3%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 1%; Cortex Magnoliae Officinalis 0.5%; The Radix Angelicae Dahuricae 1%; Radix Platycodonis 3%.
The percentage by weight of the Chinese patent medicine preparation of above-mentioned treatment alopecia is formed can also be Rhizoma Atractylodis 13%; Rhizoma Atractylodis Macrocephalae (parched) 5%; Radix Codonopsis 4%; Radix Angelicae Sinensis 13%; Rhizoma Chuanxiong 5%; Radix Bupleuri 10.5%; The Radix Astragali 1%; Radix Polygoni Multiflori Preparata 0.5%; Clear Rhizoma Pinelliae Preparata 0.5%; Polyporus 1%; Poria 0.5%; Semen Plantaginis 0.5%; Rhizoma Alismatis 0.5%; Semen Coicis 3%; Flos Carthami 3%; Radix Saposhnikoviae 1%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 5%; Semen Persicae 4%; Pericarpium Citri Reticulatae 5.5%; Fructus Aurantii 1%; Herba Pogostemonis 3%; Herba Eupatorii 3.5%; The Herba Lycopi 3.5%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 1%; Cortex Magnoliae Officinalis 0.5%; The Radix Angelicae Dahuricae 1.5%; Radix Platycodonis 3.5%.
The percentage by weight of the Chinese patent medicine preparation of above-mentioned treatment alopecia is formed can also be Rhizoma Atractylodis 3%; Rhizoma Atractylodis Macrocephalae (parched) 5%; Radix Codonopsis 4%; Radix Angelicae Sinensis 13%; Rhizoma Chuanxiong 1%; Radix Bupleuri 9%; The Radix Astragali 8%; Radix Polygoni Multiflori Preparata 0.8%; Clear Rhizoma Pinelliae Preparata 0.7%; Polyporus 1%; Poria 0.5%; Semen Plantaginis 3%; Rhizoma Alismatis 2%; Semen Coicis 5%; Flos Carthami 3%; Radix Saposhnikoviae 0.3%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 3%; Semen Persicae 3%; Pericarpium Citri Reticulatae 5%; Fructus Aurantii 1%; Herba Pogostemonis 6%; Herba Eupatorii 7%; The Herba Lycopi 3%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 2%; Cortex Magnoliae Officinalis 0.7%; The Radix Angelicae Dahuricae 1%; Radix Platycodonis 3%.
The present invention faces the card experience according to the traditional Chinese medical science several thousand, and inventor's clinical experience for many years, find most patient's alopecias owing to the physical function imbalance causes, the key of its etiology and pathogenesis is exactly because the blood stasis blood deficiency makes scalp Rhizoma Imperatae blood supply insufficiency, hair is lost support, thereby cause alopecia.The present invention adopted just the pathogenesis that hits replenishing QI to invigorate the spleen, enrich blood, the natural plants Chinese medicine of expelling wind and removing dampness, promoting flow of QI and blood, change silt tissue regeneration promoting, hair growth accelerating, be based on effecting a permanent cure, make that energy and blood of human body abundance, ailment said due to cold or exposure are dispeled, blood vessels are unimpeded, thereby make hair obtain nourishing, reach the purpose of treatment hair disease.The present invention can adopt Chinese powder medicine, does not destroy any effective ingredient in the medical material, is easily absorbed by the body, and makes stable curative effect reliable.It also can be made into multiple dosage forms such as pill, capsule.
The specific embodiment
According to Chinese medical theory, " send out and be Crinis Carbonisatus ", it is foster that the growth of human hair relies on moistening of blood in other words, and the key that causes alopecia is exactly because the blood stasis blood deficiency makes scalp Rhizoma Imperatae blood supply insufficiency, hair is lost support.Cause the pathogenesis of blood in human body in congestion void then to mainly contain following reason:
If ponder over, work hard, overwork or eating and drinking without temperance, eating cold and uncooked food excessively, addiction to greasy and sweet foods, of a specified duration all can cause insufficiency of the spleen leading to overabundance of dampness.Change source deficiency can cause blood deficiency, and dampness hampering qi movement then can cause qi stagnation blood stasis; Feelings will is not smooth, depression of liver-QI, can cause qi stagnation blood stasis yet.
Because essence and blood sharing the same origin, essence are hindered then blood wound, so excess of sexual intercourse can cause blood deficiency; Lose blood puerperal simultaneously, wound loses blood and also can cause blood deficiency.
Therefore the present invention is directed to the above pathogenesis that causes alopecia, be based on effecting a permanent cure, develop this Chinese medicine preparation.It comprises Rhizoma Atractylodis (1%--20%); The Rhizoma Atractylodis Macrocephalae (stir-fry) (1%--12%); The Radix Astragali (1%--20%); Radix Codonopsis (3%--30%); Radix Angelicae Sinensis (2%--27%); Radix Polygoni Multiflori (system) (0.5%--10%); The Rhizoma Pinelliae (clear system) (0.5%--2%); Polyporus (1%--10%); Poria (0.5%--10%); Semen Plantaginis (0.5%--10%); Rhizoma Alismatis (0.5%--10%); Semen Coicis (3%-30%); Herba Pogostemonis (3%--30%); Herba Eupatorii (3%--30%); Rhizoma Chuanxiong (1%--18%); Flos Carthami (3%--30%); Radix Saposhnikoviae (0.1%--10%); Radix Paeoniae Rubra (3%--30%); Herba Lycopi (3%--30%); Radix Salviae Miltiorrhizae (3%--30%); Rhizoma Corydalis (3%--30%); Semen Persicae (3%--30%); Pericarpium Citri Reticulatae (5%--30%); Pericarpium Citri Reticulatae Viride (1%--30%); Fructus Aurantii (1%-10%); Cortex Magnoliae Officinalis (0.5%--20%); Radix Bupleuri (3%--25%); The Radix Angelicae Dahuricae (1%--10%); Radix Platycodonis (3%--30%).
Wherein Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae (stir-fry), Radix Codonopsis, Radix Angelicae Sinensis, Rhizoma Chuanxiong and Radix Bupleuri are principal agent, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae (stir-fry) but invigorating the spleen and benefiting QI, activating the spleen damp eliminating; But Radix Codonopsis invigorating the spleen and replenishing QI; Radix Angelicae Sinensis can be enriched blood, be invigorated blood circulation; But Rhizoma Chuanxiong activating blood circulation to dissipate blood stasis; But Radix Bupleuri depressed liver-energy dispersing and QI regulating.
Pericarpium Citri Reticulatae, Fructus Aurantii, the Rhizoma Pinelliae (clear system), Polyporus, Poria, Semen Plantaginis, Rhizoma Alismatis, the Radix Astragali, Flos Carthami, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Saposhnikoviae, Radix Polygoni Multiflori (system) and Semen Coicis are accessory drugs, and Pericarpium Citri Reticulatae can be regulated the flow of vital energy, and are used for strengthening the effect of the spleen invigorating of Rhizoma Atractylodis; But the Fructus Aurantii circulation of qi promoting is used for strengthening the soothing the liver effect of Radix Bupleuri; Come the dampness stomach function regulating with the Rhizoma Pinelliae (clear system), come promoting diuresis to eliminate damp pathogen with Polyporus, Poria, Semen Plantaginis and Rhizoma Alismatis, to strengthen the effect of Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae (stir-fry) invigorating the spleen to clear away damp pathogen; Strengthen the effect of Radix Codonopsis QI invigorating with the Radix Astragali; Strengthen the effect that Rhizoma Chuanxiong is invigorated blood circulation with Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Semen Persicae and Flos Carthami.
Herba Pogostemonis, Herba Eupatorii, Cortex Magnoliae Officinalis, Herba Lycopi, Rhizoma Corydalis and Pericarpium Citri Reticulatae Viride are adjuvant drug.But Herba Pogostemonis, Herba Eupatorii removing dampness by means of aromatics; The feasible conductance of Cortex Magnoliae Officinalis stagnates; Herba Lycopi, Rhizoma Corydalis can invigorating blood circulation addictions; Pericarpium Citri Reticulatae Viride can be regulated the flow of vital energy.
The Radix Angelicae Dahuricae, Radix Platycodonis are messenger drug, and priming is up, through sick institute.
The present invention's Rhizoma Atractylodis, it both can the same Rhizoma Atractylodis Macrocephalae (stir-fry), the Rhizoma Pinelliae (clear system), Polyporus, Poria, Semen Plantaginis, Rhizoma Alismatis, Semen Coicis, Herba Pogostemonis, Herba Eupatorii, the Radix Astragali, Radix Codonopsis cooperate the effect that reaches invigorating the spleen to clear away damp pathogen, QI invigorating and blood producing, can cooperate Radix Saposhnikoviae, Radix Polygoni Multiflori (system) to reach and dispel ailment said due to cold or exposure again, blood vessels must be logical, and hair must be supported.
Because incur loss through delay sometimes was retarded by silt for a long time more when this disease was gone to a doctor,, dredge its blood vessels so cooperate group's blood circulation promoting medicines such as Flos Carthami, Semen Persicae, Radix Paeoniae Rubra, Herba Lycopi, Radix Salviae Miltiorrhizae with Rhizoma Chuanxiong.Cooperate the merit of QI regulating medicine such as Fructus Aurantii, Pericarpium Citri Reticulatae Viride simultaneously with invigorating blood circulation of enhancing addiction.In view of primary disease, though blood deficiency is arranged, mostly be insufficiency of the spleen leading to overabundance of dampness, the change source is not enough and cause the hemopoietic deficiency, if with the greasy product of enriching blood of multiple taste, common merit of enriching blood does not reach, and decreases resembling and giving birth to of damage of the spleen stomach, so use in the side Radix Polygoni Multiflori, Radix Angelicae Sinensis with its blood.
Clinical alopecia causes because of normal heterozygosis, causes a disease jointly or reciprocal causation.How and not assorted during event was write out a prescription, medicine was established at the Different types of etiopathogenises pathogenesis,, and is numerous and not random, respectively has it main, and each medicine share, and reaches the same goal very on the way, plays hemopoietic altogether to promote blood circulation the merit of hair growth accelerating.
Production technology of the present invention following (is example with the powder production technology):
1) sampling observation medical material, clean;
2) adopt and to guarantee that the method for the non-volatile medical material property of medicine dries medical material;
3) with the medical material proportioning, pulverize, sieve;
4) sterilization;
5) mix;
6) packing.
Below be concrete proportioning example of the present invention:
Embodiment 1: the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia consists of Rhizoma Atractylodis 8.6%; The Rhizoma Atractylodis Macrocephalae (stir-fry) 7%; Radix Codonopsis 4.1%; Radix Angelicae Sinensis 15%; Rhizoma Chuanxiong 4%; Radix Bupleuri 11%; The Radix Astragali 3.3%; Radix Polygoni Multiflori (system) 3%; The Rhizoma Pinelliae (clear system) 1.5%; Polyporus 1%; Poria 1.3%; Semen Plantaginis 0.7%; Rhizoma Alismatis 0.9%; Semen Coicis 3%; Flos Carthami 3%; Radix Saposhnikoviae 0.1%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 3%; Semen Persicae 3%; Pericarpium Citri Reticulatae 5%; Fructus Aurantii 1%; Herba Pogostemonis 3%; Herba Eupatorii 3%; The Herba Lycopi 3%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 1%; Cortex Magnoliae Officinalis 0.5%; The Radix Angelicae Dahuricae 1%; Radix Platycodonis 3%.
Embodiment 2: the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia is formed can also be Rhizoma Atractylodis 13%; The Rhizoma Atractylodis Macrocephalae (stir-fry) 5%; Radix Codonopsis 4%; Radix Angelicae Sinensis 13%; Rhizoma Chuanxiong 5%; Radix Bupleuri 10.5%; The Radix Astragali 1%; Radix Polygoni Multiflori (system) 0.5%; The Rhizoma Pinelliae (clear system) 0.5%; Polyporus 1%; Poria 0.5%; Semen Plantaginis 0.5%; Rhizoma Alismatis 0.5%; Semen Coicis 3%; Flos Carthami 3%; Radix Saposhnikoviae 1%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 5%; Semen Persicae 4%; Pericarpium Citri Reticulatae 5.5%; Fructus Aurantii 1%; Herba Pogostemonis 3%; Herba Eupatorii 3.5%; The Herba Lycopi 3.5%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 1%; Cortex Magnoliae Officinalis 0.5%; The Radix Angelicae Dahuricae 1.5%; Radix Platycodonis 3.5%.
Embodiment 3: the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia is formed can also be Rhizoma Atractylodis 3%; The Rhizoma Atractylodis Macrocephalae (stir-fry) 5%; Radix Codonopsis 4%; Radix Angelicae Sinensis 13%; Rhizoma Chuanxiong 1%; Radix Bupleuri 9%; The Radix Astragali 8%; Radix Polygoni Multiflori (system) 0.8%; The Rhizoma Pinelliae (clear system) 0.7%; Polyporus 1%; Poria 0.5%; Semen Plantaginis 3%; Rhizoma Alismatis 2%; Semen Coicis 5%; Flos Carthami 3%; Radix Saposhnikoviae 0.3%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 3%; Semen Persicae 3%; Pericarpium Citri Reticulatae 5%; Fructus Aurantii 1%; Herba Pogostemonis 6%; Herba Eupatorii 7%; The Herba Lycopi 3%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 2%; Cortex Magnoliae Officinalis 0.7%; The Radix Angelicae Dahuricae 1%; Radix Platycodonis 3%.
Claims (4)
1, a kind of Chinese patent medicine preparation for the treatment of alopecia is characterized in that: it is Rhizoma Atractylodis 1%-20% that the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia is formed; Rhizoma Atractylodis Macrocephalae (parched) 1%-12%; Radix Codonopsis 3%-30%; Radix Angelicae Sinensis 2%-27%; Rhizoma Chuanxiong 1%-18%; Radix Bupleuri 3%-25%; Radix Astragali 1%-20%; Radix Polygoni Multiflori Preparata 0.5%-10%; Clear Rhizoma Pinelliae Preparata 0.5%-2%; Polyporus 1%-10%; Poria 0.5%-10%; Semen Plantaginis 0.5%-10%; Rhizoma Alismatis 0.5%-10%; Semen Coicis 3%-30%; Flos Carthami 3%-30%; Radix Saposhnikoviae 0.1%-10%; Radix Paeoniae Rubra 3%-30%; Radix Salviae Miltiorrhizae 3%-30%; Semen Persicae 3%-30%; Pericarpium Citri Reticulatae 5%-30%; Fructus Aurantii 1%-10%; Herba Pogostemonis 3%-30%; Herba Eupatorii 3%-30%; Herba Lycopi 3%-30%; Rhizoma Corydalis 3%-30%; Pericarpium Citri Reticulatae Viride 1%-30%; Cortex Magnoliae Officinalis 0.5%-20%; Radix Angelicae Dahuricae 1%-10%; Radix Platycodonis 3%-30%.
2, according to the Chinese patent medicine preparation of the described treatment alopecia of claim 1, it is characterized in that: the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia consists of Rhizoma Atractylodis 8.6%; Rhizoma Atractylodis Macrocephalae (parched) 7%; Radix Codonopsis 4.1%; Radix Angelicae Sinensis 15%; Rhizoma Chuanxiong 4%; Radix Bupleuri 11%; The Radix Astragali 3.3%; Radix Polygoni Multiflori Preparata 3%; Clear Rhizoma Pinelliae Preparata 1.5%; Polyporus 1%; Poria 1.3%; Semen Plantaginis 0.7%; Rhizoma Alismatis 0.9%; Semen Coicis 3%; Flos Carthami 3%; Radix Saposhnikoviae 0.1%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 3%; Semen Persicae 3%; Pericarpium Citri Reticulatae 5%; Fructus Aurantii 1%; Herba Pogostemonis 3%; Herba Eupatorii 3%; The Herba Lycopi 3%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 1%; Cortex Magnoliae Officinalis 0.5%; The Radix Angelicae Dahuricae 1%; Radix Platycodonis 3%.
3, the Chinese patent medicine preparation of treatment alopecia according to claim 1 is characterized in that: the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia consists of Rhizoma Atractylodis 13%; Rhizoma Atractylodis Macrocephalae (parched) 5%; Radix Codonopsis 4%; Radix Angelicae Sinensis 13%; Rhizoma Chuanxiong 5%; Radix Bupleuri 10.5%; The Radix Astragali 1%; Radix Polygoni Multiflori Preparata 0.5%; Clear Rhizoma Pinelliae Preparata 0.5%; Polyporus 1%; Poria 0.5%; Semen Plantaginis 0.5%; Rhizoma Alismatis 0.5%; Semen Coicis 3%; Flos Carthami 3%; Radix Saposhnikoviae 1%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 5%; Semen Persicae 4%; Pericarpium Citri Reticulatae 5.5%; Fructus Aurantii 1%; Herba Pogostemonis 3%; Herba Eupatorii 3.5%; The Herba Lycopi 3.5%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 1%; Cortex Magnoliae Officinalis 0.5%; The Radix Angelicae Dahuricae 1.5%; Radix Platycodonis 3.5%.
4, the Chinese patent medicine preparation of treatment alopecia according to claim 1 is characterized in that: the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia consists of Rhizoma Atractylodis 3%; Rhizoma Atractylodis Macrocephalae (parched) 5%; Radix Codonopsis 4%; Radix Angelicae Sinensis 13%; Rhizoma Chuanxiong 1%; Radix Bupleuri 9%; The Radix Astragali 8%; Radix Polygoni Multiflori Preparata 0.8%; Clear Rhizoma Pinelliae Preparata 0.7%; Polyporus 1%; Poria 0.5%; Semen Plantaginis 3%; Rhizoma Alismatis 2%; Semen Coicis 5%; Flos Carthami 3%; Radix Saposhnikoviae 0.3%; Radix Paeoniae Rubra 3%; Radix Salviae Miltiorrhizae 3%; Semen Persicae 3%; Pericarpium Citri Reticulatae 5%; Fructus Aurantii 1%; Herba Pogostemonis 6%; Herba Eupatorii 7%; The Herba Lycopi 3%; Rhizoma Corydalis 3%; Pericarpium Citri Reticulatae Viride 2%; Cortex Magnoliae Officinalis 0.7%; The Radix Angelicae Dahuricae 1%; Radix Platycodonis 3%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02139561 CN1269506C (en) | 2002-11-28 | 2002-11-28 | Prepared Chinese traditional medicine for alopecia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02139561 CN1269506C (en) | 2002-11-28 | 2002-11-28 | Prepared Chinese traditional medicine for alopecia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1504210A CN1504210A (en) | 2004-06-16 |
| CN1269506C true CN1269506C (en) | 2006-08-16 |
Family
ID=34231840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02139561 Expired - Lifetime CN1269506C (en) | 2002-11-28 | 2002-11-28 | Prepared Chinese traditional medicine for alopecia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1269506C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267775A (en) * | 2014-07-14 | 2016-01-27 | 高仁丽 | Chinese patent medicinal preparation for treating alopecia disease |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100391518C (en) * | 2005-04-07 | 2008-06-04 | 韩勇 | Powder containing honeysuckle flower |
| CN100434097C (en) * | 2005-04-07 | 2008-11-19 | 韩勇 | Ophidia black snake powder |
| CN100391511C (en) * | 2005-04-07 | 2008-06-04 | 韩勇 | Peach kernel macrostem onion powder |
| CN100444885C (en) * | 2005-04-07 | 2008-12-24 | 韩勇 | Powder containing fingered citron and citron |
| CN100434110C (en) * | 2005-04-07 | 2008-11-19 | 韩勇 | Powder comprising mint and chrysanthemum |
| CN100391508C (en) * | 2005-04-07 | 2008-06-04 | 韩勇 | Yam haricot bean powder |
| CN100339100C (en) * | 2005-10-26 | 2007-09-26 | 王亚杰 | Alopecia areata treating medicine |
| CN101822629B (en) * | 2010-02-05 | 2011-08-17 | 霸王（广州）有限公司 | Special pure natural plant thick hair essence for men and preparation method thereof |
| CN101966307A (en) * | 2010-10-26 | 2011-02-09 | 长治市郊区人民医院 | Medicinal composition for treating damp-heat icterohepatitis |
-
2002
- 2002-11-28 CN CN 02139561 patent/CN1269506C/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267775A (en) * | 2014-07-14 | 2016-01-27 | 高仁丽 | Chinese patent medicinal preparation for treating alopecia disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1504210A (en) | 2004-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1084761A (en) | Bone wound medicine (gushangling) | |
| CN1203805A (en) | Health-care drink capable of preventing and curing menopathy | |
| CN1269506C (en) | Prepared Chinese traditional medicine for alopecia | |
| CN1739774A (en) | Spot eliminating and youthful looks preserving capsule | |
| CN1160559A (en) | Hepatitis B curing toxin-dissipating pill | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN100391526C (en) | Powder comprising oyster and king solomonseal root | |
| CN101156920B (en) | Oral administration and externally used drug for treating traumatic injury and its preparation method | |
| CN1270765C (en) | Medicinal wine or liquid for treating cold | |
| CN1569072A (en) | Compound chinese medicinal oral preparation for treating alopecia areata and alopecia and its preparing method | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN105267775A (en) | Chinese patent medicinal preparation for treating alopecia disease | |
| CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN106511773A (en) | Traditional Chinese medicine composite for treating dental ulcer | |
| CN1059811C (en) | Complete set of Chinese medicine preparations for curing hepatitis B | |
| CN1169546C (en) | Chinese medicine for treating hypotension | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN1075727C (en) | Shentong capsule and preparing method thereof | |
| CN1298724A (en) | Medicine for treating immunodefiiciency disease | |
| CN103028058B (en) | Traditional Chinese medicine composition for treating feebleness | |
| CN1334114A (en) | Chinese medicine for treating mastoplasia | |
| CN102600414A (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN100335113C (en) | Health face beartifying powder | |
| CN100434097C (en) | Ophidia black snake powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20060816 |